LPTX - Multiplikator P/S Leap Tx

Tandha merek leaptx.com (LPTX)

The current price-to-sales ratio on the GURU.Markets chart captures the valuation dynamics of Leap Therapeutics, Inc. (LPTX), where the 96.40 mark indicates the level of market expectations. Optimism is driven by partnerships with tech giants to develop antibodies for tumor therapy, which minimizes costs. Holding exclusive rights in niche markets guarantees flexible pricing power. Meanwhile, the environmental footprint remains minimal due to the outsourcing of research.

LPTX (Leap Therapeutics, Inc.) riwayat Rasio rega marang pendapatan saka 04.07.2022 nganti 01.04.2023

Leap Therapeutics, Inc. (LPTX) - rincian metrik lan laporan keuangan

- rega pasar lan target rega analis:
Analisis umum perusahaan:Leap Tx, LPTX
Produk asil prodhuksi Leap Tx

Leap Therapeutics, Inc. (LPTX) focuses on developing oncology drugs, while the absence of operating revenues leaves the company dependent on grants and clinical successes. The fluctuation in the P/S ratio reflects market expectations regarding future capitalization relative to current cash flows. This metric is calculated as the ratio of the business's market value to total revenue. Investors should view the extremes of this chart as signals of increased risk for a sharp valuation correction.

Perusahaan pesaing

Kapitalisasi marang pendapatan ImmunityBio Corp IBRX|Immunocore Holdings - Kapitalisasi marang pendapatan|Multiplikator P/S Janux Corp JANX|RCUS - Rasio rega marang pendapatan|ZYME (zymeworks.com) - Rasio kapitalisasi marang pendapatan|Tango Therapeutics Corp (TNGX) - Rasio rega marang pendapatan|Rega marang dodolan Iovance (IOVA)|Kapitalisasi marang pendapatan IMTX|XNCR - Multiplikator rega marang pendapatan|Kapitalisasi marang pendapatan CMPX (Compass Bio)|Kapitalisasi marang volume dodolan REPL|Multiplikator P/S LYEL (Lyell Immunopharma, Inc.)|Rasio kapitalisasi pasar marang pendapatan IPHA|Pyxis - Multiplikator P/S|Rega marang dodolan Compugen|IO Biotech, Inc. (IOBT) - Rasio rega marang pendapatan|Sutro Biopharma, Inc. - Rasio kapitalisasi pasar marang pendapatan|INKT (minktherapeutics.com) - Multiplikator P/S|Multiplikator P/S werewolftx.com|Rasio rega marang pendapatan immixbio.com (IMMX)|ALXO: Rasio rega marang dodolan|Multiplikator P/S CUE (Cue Biopharma Inc.)|PDS Biotechnology (PDSB) - Rega marang dodolan|SONN - Rasio rega marang pendapatan|MAIA Biotechnology, Inc. (MAIA) - Kapitalisasi marang pendapatan|LIMN: Multiplikator P/S|LAVA Therapeutics N.V. (LVTX) - Multiplikator P/S|Kapitalisasi marang pendapatan NXTC|INTS (Intensity Therapeutics) - Kapitalisasi marang volume dodolan|Rasio rega marang pendapatan Sensei Bio (SNSE)|TOVX (Theriva Biologics) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan gritstonebio.com GRTS|Rasio kapitalisasi pasar marang pendapatan KA|NEXI - Rasio rega marang pendapatan|Turnstone Biologics Corp. - Kapitalisasi marang volume dodolan|VCNX: Multiplikator P/S|Rasio kapitalisasi marang pendapatan HARP